A potential role for GPR55 in the regulation of energy homeostasis

Xu, 2004, Orphan G protein-coupled receptors and obesity, Eur. J. Pharmacol., 500, 243, 10.1016/j.ejphar.2004.07.029 Di Marzo, 2009, The endocannabinoid system as a link between homoeostatic and hedonic pathways involved in energy balance regulation, Int. J. Obes., 33, S18, 10.1038/ijo.2009.67 Naughton, 2013, Fatty acid modulation of the endocannabinoid system and the effect on food intake and metabolism, Int. J. Endocrinol., 2013, 361895, 10.1155/2013/361895 Ryberg, 2007, The orphan receptor GPR55 is a novel cannabinoid receptor, Br. J. Pharmacol., 152, 1092, 10.1038/sj.bjp.0707460 Seidell, 2000, Obesity, insulin resistance and diabetes: a worldwide epidemic, Br. J. Nutr., 83, S5, 10.1017/S000711450000088X Lipina, 2012, New vistas for treatment of obesity and diabetes? Endocannabinoid signalling and metabolism in the modulation of energy balance, Bioessays, 34, 681, 10.1002/bies.201200031 Cote, 2007, Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors in obese men, Int. J. Obes., 31, 692, 10.1038/sj.ijo.0803539 Matsuda, 1990, Structure of a cannabinoid receptor and functional expression of the cloned cDNA, Nature, 346, 561, 10.1038/346561a0 Munro, 1993, Molecular characterization of a peripheral receptor for cannabinoids, Nature, 365, 61, 10.1038/365061a0 Williams, 1998, Hyperphagia in pre-fed rats following oral delta9-THC, Physiol. Behav., 65, 343, 10.1016/S0031-9384(98)00170-X Izzo, 2001, Cannabinoid CB1-receptor mediated regulation of gastrointestinal motility in mice in a model of intestinal inflammation, Br. J. Pharmacol., 134, 563, 10.1038/sj.bjp.0704293 Osei-Hyiaman, 2005, Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity, J. Clin. Invest., 115, 1298, 10.1172/JCI200523057 Osei-Hyiaman, 2008, Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice, J. Clin. Invest., 118, 3160, 10.1172/JCI34827 Song, 2011, Acute cannabinoid receptor type 1 (CB1R) modulation influences insulin sensitivity by an effect outside the central nervous system in mice, Diabetologia, 54, 1181, 10.1007/s00125-011-2082-z Cabral, 2009, Emerging role of the cannabinoid receptor CB2 in immune regulation: therapeutic prospects for neuroinflammation, Expert Rev. Mol. Med., 11, e3, 10.1017/S1462399409000957 Galiegue, 1995, Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations, Eur. J. Biochem., 232, 54, 10.1111/j.1432-1033.1995.tb20780.x Maachi, 2004, Systemic low-grade inflammation is related to both circulating and adipose tissue TNFalpha, leptin and IL-6 levels in obese women, Int. J. Obes. Relat. Metab. Disord., 28, 993, 10.1038/sj.ijo.0802718 Romero-Zerbo, 2012, Overexpression of cannabinoid CB2 receptor in the brain induces hyperglycaemia and a lean phenotype in adult mice, J. Neuroendocrinol., 24, 1106, 10.1111/j.1365-2826.2012.02325.x Jarai, 1999, Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors, Proc. Natl. Acad. Sci. U. S. A., 96, 14136, 10.1073/pnas.96.24.14136 Romero-Zerbo, 2011, A role for the putative cannabinoid receptor GPR55 in the islets of Langerhans, J. Endocrinol., 211, 177, 10.1530/JOE-11-0166 Moreno-Navarrete, 2012, The l-alpha-lysophosphatidylinositol/GPR55 system and its potential role in human obesity, Diabetes, 61, 281, 10.2337/db11-0649 Kapur, 2009, Atypical responsiveness of the orphan receptor GPR55 to cannabinoid ligands, J. Biol. Chem., 284, 29817, 10.1074/jbc.M109.050187 Oka, 2007, Identification of GPR55 as a lysophosphatidylinositol receptor, Biochem. Biophys. Res. Commun., 362, 928, 10.1016/j.bbrc.2007.08.078 Oka, 2009, 2-Arachidonoyl-sn-glycero-3-phosphoinositol: a possible natural ligand for GPR55, J. Biochem., 145, 13, 10.1093/jb/mvn136 Henstridge, 2010, GPR55 ligands promote receptor coupling to multiple signalling pathways, Br. J. Pharmacol., 160, 604, 10.1111/j.1476-5381.2009.00625.x Pertwee, 2010, International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB(1) and CB(2), Pharmacol. Rev., 62, 588, 10.1124/pr.110.003004 Sawzdargo, 1999, Identification and cloning of three novel human G protein-coupled receptor genes GPR52, PsiGPR53 and GPR55: GPR55 is extensively expressed in human brain, Brain Res. Mol. Brain Res., 64, 193, 10.1016/S0169-328X(98)00277-0 Schicho, 2011, The atypical cannabinoid O-1602 protects against experimental colitis and inhibits neutrophil recruitment, Inflamm. Bowel Dis., 17, 1651, 10.1002/ibd.21538 Lin, 2011, A novel CB receptor GPR55 and its ligands are involved in regulation of gut movement in rodents, Neurogastroenterol. Motil., 23, 10.1111/j.1365-2982.2011.01742.x Lauckner, 2008, GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current, Proc. Natl. Acad. Sci. U. S. A., 105, 2699, 10.1073/pnas.0711278105 Waldeck-Weiermair, 2008, Integrin clustering enables anandamide-induced Ca21 signaling in endothelial cells via GPR55 by protection against CB1-receptor-triggered repression, J. Cell Sci., 121, 1704, 10.1242/jcs.020958 Johns, 2007, The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects, Br. J. Pharmacol., 152, 825, 10.1038/sj.bjp.0707419 Whyte, 2009, The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo, Proc. Natl. Acad. Sci. U. S. A., 106, 16511, 10.1073/pnas.0902743106 Henstridge, 2009, The GPR55 ligand l-alpha-lysophosphatidylinositol promotes RhoA-dependent Ca21 signaling and NFAT activation, FASEB J., 23, 183, 10.1096/fj.08-108670 Ross, 2009, The enigmatic pharmacology of GPR55, Trends Pharmacol. Sci., 30, 156, 10.1016/j.tips.2008.12.004 Anavi-Goffer, 2012, Modulation of l-alpha-lysophosphatidylinositol/GPR55 mitogen-activated protein kinase (MAPK) signaling by cannabinoids, J. Biol. Chem., 287, 91, 10.1074/jbc.M111.296020 McHugh, 2010, N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor, BMC Neurosci., 11, 44, 10.1186/1471-2202-11-44 Kotsikorou, 2011, Identification of the GPR55 agonist binding site using a novel set of high-potency GPR55 selective ligands, Biochemistry, 50, 5633, 10.1021/bi200010k Kargl, 2012, The cannabinoid receptor CB1 modulates the signaling properties of the lysophosphatidylinositol receptor GPR55, J. Biol. Chem., 287, 44234, 10.1074/jbc.M112.364109 Kargl, 2013, A selective antagonist reveals a potential role of G protein-coupled receptor 55 in platelet and endothelial cell function, J. Pharmacol. Exp. Ther., 346, 54, 10.1124/jpet.113.204180 Oka, 2010, Lysophosphatidylinositol induces rapid phosphorylation of p38 mitogen-activated protein kinase and activating transcription factor 2 in HEK293 cells expressing GPR55 and IM-9 lymphoblastoid cells, J. Biochem., 147, 671, 10.1093/jb/mvp208 Smith, 2010, Allostery at G protein-coupled receptor homo- and heteromers: uncharted pharmacological landscapes, Pharmacol. Rev., 62, 701, 10.1124/pr.110.002667 Landsman, 1997, SR141716A is an inverse agonist at the human cannabinoid CB1 receptor, Eur. J. Pharmacol., 334, R1, 10.1016/S0014-2999(97)01160-6 Bluher, 2006, Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity, Diabetes, 55, 3053, 10.2337/db06-0812 Balenga, 2011, GPR55 regulates cannabinoid 2 receptor-mediated responses in human neutrophils, Cell Res., 21, 1452, 10.1038/cr.2011.60 Andradas, 2011, The orphan G protein-coupled receptor GPR55 promotes cancer cell proliferation via ERK, Oncogene, 30, 245, 10.1038/onc.2010.402 Ford, 2010, A role for l-alpha-lysophosphatidylinositol and GPR55 in the modulation of migration, orientation and polarization of human breast cancer cells, Br. J. Pharmacol., 160, 762, 10.1111/j.1476-5381.2010.00743.x Pineiro, 2011, The putative cannabinoid receptor GPR55 defines a novel autocrine loop in cancer cell proliferation, Oncogene, 30, 142, 10.1038/onc.2010.417 Huang, 2011, Anandamide exerts its antiproliferative actions on cholangiocarcinoma by activation of the GPR55 receptor, Lab. Invest., 91, 1007, 10.1038/labinvest.2011.62 Perez-Gomez, 2012, The orphan receptor GPR55 drives skin carcinogenesis and is upregulated in human squamous cell carcinomas, Oncogene, 32, 2534, 10.1038/onc.2012.278 Staton, 2008, The putative cannabinoid receptor GPR55 plays a role in mechanical hyperalgesia associated with inflammatory and neuropathic pain, Pain, 139, 225, 10.1016/j.pain.2008.04.006 Diaz-Arteaga, 2012, The atypical cannabinoid O-1602 stimulates food intake and adiposity in rats, Diabetes Obes. Metab., 14, 234, 10.1111/j.1463-1326.2011.01515.x Elayat, 1995, An immunocytochemical and morphometric study of the rat pancreatic islets, J. Anat., 186, 629 Butler, 2003, Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes, Diabetes, 52, 102, 10.2337/diabetes.52.1.102 Weyer, 1999, The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus, J. Clin. Invest., 104, 787, 10.1172/JCI7231 Kim, 2008, Role of mitochondrial dysfunction in insulin resistance, Circ. Res., 102, 401, 10.1161/CIRCRESAHA.107.165472 Carey, 2009, Novel pharmacological approaches to combat obesity and insulin resistance: targeting skeletal muscle with ‘exercise mimetics’, Diabetologia, 52, 2015, 10.1007/s00125-009-1420-x Akimoto, 2005, Exercise stimulates Pgc-1alpha transcription in skeletal muscle through activation of the p38 MAPK pathway, J. Biol. Chem., 280, 19587, 10.1074/jbc.M408862200 Somwar, 2001, GLUT4 translocation precedes the stimulation of glucose uptake by insulin in muscle cells: potential activation of GLUT4 via p38 mitogen-activated protein kinase, Biochem. J., 359, 639, 10.1042/0264-6021:3590639 Turcotte, 2005, ERK1/2 inhibition prevents contraction-induced increase in plasma membrane FAT/CD36 content and FA uptake in rodent muscle, Acta Physiol. Scand., 184, 131, 10.1111/j.1365-201X.2005.01445.x Chen, 2002, Activation of the ERK pathway and atypical protein kinase C isoforms in exercise- and aminoimidazole-4-carboxamide-1-beta-d-riboside (AICAR)-stimulated glucose transport, J. Biol. Chem., 277, 23554, 10.1074/jbc.M201152200 Leng, 2004, Effects of insulin, contraction, and phorbol esters on mitogen-activated protein kinase signaling in skeletal muscle from lean and ob/ob mice, Diabetes, 53, 1436, 10.2337/diabetes.53.6.1436 Yu, 2013, Differential activation of cultured neonatal cardiomyocytes by plasmalemmal versus intracellular G protein-coupled receptor 55, J. Biol. Chem., 288, 22481, 10.1074/jbc.M113.456178 Cavuoto, 2007, The expression of receptors for endocannabinoids in human and rodent skeletal muscle, Biochem. Biophys. Res. Commun., 364, 105, 10.1016/j.bbrc.2007.09.099 Mutungi, 2008, The expression of NFATc1 in adult rat skeletal muscle fibres, Exp. Physiol., 93, 399, 10.1113/expphysiol.2007.040485